GDNF and pancreatic neoplasm: The G691S RET polymorphism was reported to enhance the response of RET to glial cell line-derived neurotrophic factor (GDNF) and was correlated with the aggressive phenotype of pancreatic cancers [30] and cutaneous malignant melanomas [31].